Efficacy of an Ondansetron Orally Disintegrating Tablet: A Novel Oral Formulation of this 5-HT3 Receptor Antagonist in the Treatment of Fractionated Radiotherapy-Induced Nausea and Emesis

This publication has 10 references indexed in Scilit:

• A randomised placebo controlled study with ondansetron in patients undergoing fractionated radiotherapy
  Annals of Oncology, 1996
• Efficacy of Oral Ondansetron in the Prevention of Emesis in Outpatients Receiving Cyclophosphamide-based Chemotherapy
  Annals of Internal Medicine, 1993
• Comparison of the anti-emetic efficacy of different doses of ondansetron, given as either a continuous infusion or a single intravenous dose, in acute cisplatin-induced emesis. A multicentre, double-blind, randomised, parallel group study
  British Journal of Cancer, 1992
• Ondansetron Compared with Metoclopramide in the Control of Emesis and Quality of Life during Repeated Chemotherapy for Breast Cancer
  Oncology, 1992
• The final assessment of a randomized double-blind comparative study of ondansetron vs. metoclopramide in the prevention of nausea and vomiting following high-dose upper abdominal irradiation
  Clinical Oncology, 1991
• Emesis during past pregnancy: A new prognostic factor in chemotherapy-induced emesis
  Annals of Oncology, 1990
• Results of a randomized, double-blind comparative study of ondansetron and metoclopramide in the prevention of nausea and vomiting following high-dose upper abdominal irradiation
  Clinical Oncology, 1990
• Vomiting associated with whole body irradiation
  Clinical Radiology, 1987
• The effect of a susceptibility to motion sickness on the side effects of cancer chemotherapy
  Cancer, 1985
• The acute radiation syndrome
  Clinical Radiology, 1979